掛號頁面

胃腸肝膽科

胃腸肝膽科

  • 鄭羣翰

    主治醫師

    胃腸肝膽科 :
    門診掛號  

  • 現職

      • 台東馬偕紀念醫院腸胃內科主治醫師

    主要學歷

      • 國立陽明大學醫學系

    主要經歷

      • 台東馬偕紀念醫院胃腸肝膽科主治醫師
      • 馬偕紀念醫院胃腸肝膽科主治醫師
      • 馬偕紀念醫院胃腸肝膽科總醫師
      • 馬偕紀念醫院內科住院醫師
      • 日本北里大學內視鏡中心訓練
      • 日本順天堂醫院國際肝癌射頻燒灼術訓練
      • 日本東京大學內視鏡中心訓練
      • 教育部部定講師

主治項目或專長

MAJOR SERVICE

消化性潰瘍、胃食道逆流、腸胃道腫瘤、肝炎、肝硬化、肝腫瘤、膽道疾病、腸燥症及大腸疾病、腹部超音波、消化道內視鏡檢查


論文研究

  • 1.Cheng CH, Chen MJ, Wang HY, et al. Fatal aorto-esophageal fistula bleeding due to previous esophageal ulcer：Report of a Case. Gastroenterol J Taiwan; Vol. 30, No. 4, 2013

  • 2.Cheng CH, Chen HL, Lin IT, et al. The genotype distribution of hepatitis C in southeastern Taiwan: Clinical characteristics, racial difference, and therapeutic response. Kaohsiung J Med Sci. 2015 Nov;31(11):597-602.
  • 3.Chang CW, Cheng CH, Wang TE, et al. Impact of Therapeutic Interventions on Survival of Elderly Patients with Gallbladder Carcinoma: A 10-year Single Center Experience. Int J Gerontol. 2015 Dec; 9(4): 228–232.
  • 4.Cheng CH, Wu CH, Bair MJ. Endoscopic-ultrasound-guided cystogastrostomy for walled-off necrosis of the pancreas. Advances in Digestive Medicine. 2016; 3: 207-208. 
  • 5.Cheng CH, Chen MJ. A Tiny Object Embedded in Cervical Esophagus. Int J Gerontol. 2016; 10:119-120.
  • 6.Cheng CH, Bair MJ. Spontaneous Splenic Infarction as an Uncommon Cause of Fever in a Cirrhotic Patient. Int J Gerontol. 2017 Jun; 11(2): 121-124.
  • 7.Wong MW, Chen MJ, Chen HL, Kuo YC, Lin IT, Wu CH, Lee YK, Cheng CH, Bair MJ. Application of chronic liver failure-sequential organ failure assessment score for the predication of mortality after esophageal variceal hemorrhage post endoscopic ligation. PLoS One. 2017 Aug 2;12(8):e0182529. doi: 10.1371/journal.pone.0182529
  • 8.Cheng CH, Lin CC, Chen HL, et al. High frequencies of a favorable IL-28B rs8099917 polymorphism and the clinical implications in patients with HCV in one multiracial area of Taiwan. Kaohsiung J Med Sci. 2017 Oct;33(10):510-515.
  • 9.Cheng CH, Lin CC, Chen HL, et al. Genotype distribution and treatment response among incarcerated drug-dependent patients with chronic hepatitis C infection. PLoS One. 2018 Feb 1;13(2):e0191799. doi: 10.1371/journal.pone.0191799.
  • 10.Wu MR, Hsiao CY, Cheng CH, et al. Is endotracheal intubation a non-beneficial treatment in patients with respiratory failure due to paraquat poisoning? PLoS One. 2018 Mar 28;13(3):e0195071. doi: 10.1371/journal.pone.0195071
  • 11.Liao FC, Hsiao CY, Chao CL, Cheng CH, et al. Impact of Moderate to Severe Chronic Kidney Disease for Long Term Survival of Implantable Cardioverter Defibrillator Patients in Taiwan. Int J Gerontol. Volume 12, Issue 2, June 2018, Pages 89-93.
  • 12.Cheng CH, Wu MR, Chao CL, et al. Palliative Care for End-Stage Cirrhotic Patients in Intensive Care Units. Int J Gerontol. Volume 13, Issue 2, June 2019, Page 176~180.
  • 13.Cheng CH, Chu CY, Chen HL, et al. Long-term histological change in chronic hepatitis C patients who had received peginterferon plus ribavirin therapy with sustained virological response. J Formos Med Assoc. 2019 Jul;118(7):1129-1137. doi: 10.1016/j.jfma.2018.11.005
  • 14.Huang CF, Hung CH, Cheng PN, Bair MJ, Huang YH, Kao JH, Hsu SJ, Lee PL, Chen JJ, Chien RN, Peng CY, Lin CY, Hsieh TY, Cheng CH, et al. An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions. J Infect Dis. 2019 Jul 19;220(4):557-566. doi: 10.1093/infdis/jiz154
  • 15.Chen CP, Cheng CY, Zou H, Cheng CH, et al. Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings. J Microbiol Immunol Infect. 2019 Aug;52(4):556-562. doi: 10.1016/j.jmii.2018.10.002
  • 16.Cheng CH, Chu CY, Chen HL, et al. Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C. J Microbiol Immunol Infect. 2020 Aug;53(4):542-549. doi: 10.1016/j.jmii.2019.09.002
  • 17.Cheng CH, Chu CY, Chen HL, et al. Direct-acting antiviral therapy of chronic hepatitis C improves liver fibrosis, assessed by histological examination and laboratory markers. J Formos Med Assoc. 2021 May;120(5):1259-1268. doi: 10.1016/j.jfma.2020.11.018
  • 18.Cheng CH, Chu CY, Chen HL, et al. Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients. Front Endocrinol. 2022 Jan 13;12:799382. doi: 10.3389/fendo.2021.799382.